Ensuring Uptake of Vaccines against SARS-CoV-2
Open Access
- 1 October 2020
- journal article
- editorial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 383 (14), 1296-1299
- https://doi.org/10.1056/NEJMp2020926
Abstract
As Covid-19 continues to exact a heavy toll, development of a vaccine appears the most promising means of restoring normalcy to civil life. Perhaps no scientific breakthrough is more eagerly anticipated. But bringing a vaccine to market is only half the challenge; also critical is ensuring a high enough vaccination rate to achieve herd immunity. Concerningly, a recent poll found that only 49% of Americans planned to get vaccinated against SARS-CoV-2.1This publication has 3 references indexed in Scilit:
- Adverse Consequences of Rushing a SARS-CoV-2 VaccineJama-Journal Of The American Medical Association, 2020
- Planning for a COVID-19 Vaccination ProgramJama-Journal Of The American Medical Association, 2020
- Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus VaccinationAmerican Journal of Public Health, 2012